These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85. A new potential approach to inotropic therapy in the treatment of heart failure: urocortin. Garg V; Frishman WH Cardiol Rev; 2013; 21(3):160-5. PubMed ID: 23269034 [TBL] [Abstract][Full Text] [Related]
86. The role of urocortins in the cardiovascular system. Walczewska J; Dzieza-Grudnik A; Siga O; Grodzicki T J Physiol Pharmacol; 2014 Dec; 65(6):753-66. PubMed ID: 25554979 [TBL] [Abstract][Full Text] [Related]
87. The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family. Davidson SM; Rybka AE; Townsend PA Biochem Pharmacol; 2009 Jan; 77(2):141-50. PubMed ID: 18817752 [TBL] [Abstract][Full Text] [Related]
88. [New inotropic agents in the treatment of congestive heart failure]. Freitas M Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458 [TBL] [Abstract][Full Text] [Related]
89. Urocortins: Actions in health and heart failure. Rademaker MT; Richards AM Clin Chim Acta; 2017 Nov; 474():76-87. PubMed ID: 28887029 [TBL] [Abstract][Full Text] [Related]
90. Cardiac dysfunction in heart failure: the cardiologist's love affair with time. Brutsaert DL Prog Cardiovasc Dis; 2006; 49(3):157-81. PubMed ID: 17084177 [TBL] [Abstract][Full Text] [Related]